'Ketamine Queen' sentenced to 15 years in death of 'Friends' star Matthew Perry
A drug dealer dubbed the "Ketamine Queen" was sentenced on Wednesday to 15 years in prison in connection with "Friends" star Matthew Perry's 2023 death, including her role in supplying the dose of the powerful anesthetic that killed the actor...
schedule
09:56 visibility
59 views
Source: France 24
A drug dealer dubbed the "Ketamine Queen" was sentenced on Wednesday to 15 years in prison in connection with "Friends" star Matthew Perry's 2023 death, including her role in supplying the dose of the powerful anesthetic that killed the actor. Jasveen Sangha, who admitted to running a "stash house" for illegal narcotics out of her home in the North Hollywood district of Los Angeles, pleaded guilty in September to five felony drug counts stemming from Perry's death at age 54.
The singer has filed a lawsuit in the Supreme Court against the deputy prime minister, alleging a violation of his right to honour and seeking €50,000 over remarks she made about sexual abuse allegations brought by two former employees.
Rahul Gandhi and other leaders of the main opposition Congress party have been dragged away by police from a rally outside PM Narendra Modi's residence, a day after dozens of youth protesters were arrested. Follow DW.
Snap is the latest big tech company to settle a lawsuit that claimed social media platforms are harmful to children and young adults. The company has reached a “tentative” agreement in a case that was set to go to trial later this month...
The leaders of India's youth-led Cockroach movement are vowing to continue protesting a day after police cracked down on demonstrators. They have been demanding the country's education minister, Dharmendra Pradhan, resign amid repeated leaks for...
Clashes broke out between security personnel and protesters in the Italian city of Bologna. Demonstrators out on the street, calling for accountability after a man died whilst being detained by police...
France 24
We use cookies to improve your experience. By continuing to use this site, you agree to our use of cookies. Learn more